EMERYVILLE, Calif. — August 25, 2025 — Leads & Copy — 4D Molecular Therapeutics (Nasdaq: FDMT), a biotechnology company, announced its management will participate in fireside chats at investor conferences in September. Management will also be available for one-on-one meetings.
The conferences include the Cantor Global Healthcare Conference on Sept. 4, the H.C. Wainwright 27th Annual Global Investment Conference on Sept. 9, and the Morgan Stanley Annual Global Healthcare Conference on Sept. 9.
Webcasts will be archived for one year on the “Investors” section of the 4DMT website.
4DMT is focused on advancing durable and disease-targeted therapeutics.
Contacts:
Media: Jenn Gordon, dna Communications, Media@4DMT.com
Investors: Julian Pei, Head of Investor Relations and Strategic Finance, Investor.Relations@4DMT.com
Source: 4D Molecular Therapeutics
